Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic Influences.

Journal of geriatric psychiatry and neurology - 1 Mar 2016

Peters Matthew E, Vaidya Vijay, Drye Lea T, Devanand Davangere P, Mintzer Jacobo E, Pollock Bruce G, Porsteinsson Anton P, Rosenberg Paul B, Schneider Lon S, Shade David M, Weintraub Daniel, Yesavage Jerome, Lyketsos Constantine G, Avramopoulos Dimitri

Abstract excerpt

OBJECTIVE: To assess potential genetic influences on citalopram treatment efficacy for agitation in individuals with Alzheimer dementia (AD). Six functional genetic variants were studied in the following genes: serotonin receptor 2A (HTR2A-T102C), serotonin receptor 2C (HTR2C-Cys23Ser), serotonin transporter (5HTT-LPR), brain-derived neurotropic factor (BDNF-Val66Met), apolipoprotein E (ε2, ε3, ε4 variants), and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Brain-Derived Neurotrophic Factor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Caregivers

Share to Citalopram

Share to Cytochrome P-450 CYP2C19

Share to Double-Blind Method

Share to Receptors, Serotonin

Share to Selective Serotonin Reuptake Inhibitors

Source

Open in PubMed Open full text

Identifiers

PMID: 26303700
DOI: 10.1177/0891988715601735
PMCID: PMC5166612

Genes

BDNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic Influences.PMID 26303700Read ↗

Sertraline for the treatment of depression in Alzheimer disease: genetic influences.Semantic proximity Read ↗

Future Trends in the Pharmacogenomics of Brain Disorders and Dementia: Influence of APOE and CYP2D6 VariantsSemantic proximity Read ↗

Influence of pharmacogenetic factors on Alzheimer's disease therapeutics.Semantic proximity Read ↗

Association of the Serotonin Transporter and Receptor Gene Polymorphisms in Neuropsychiatric Symptoms in Alzheimer DiseaseSemantic proximity Read ↗

Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in DementiaSemantic proximity Read ↗

Pharmacogenomics and therapeutic strategies for dementiaSemantic proximity Read ↗

Allelic variation at the A218C tryptophan hydroxylase polymorphism influences agitation and aggression in Alzheimer's disease.Semantic proximity Read ↗

Pharmacogenetics of Anxiety and Depression in Alzheimer’s DiseaseSemantic proximity Read ↗

Serotonergic system genes in psychosis of Alzheimer dementia: meta-analysis.Semantic proximity Read ↗

The Association between 5HT2A T102C and Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease: A Meta-Analysis.Semantic proximity Read ↗

Effect of genetic polymorphisms on Alzheimer’s disease treatment outcomes: an updateSemantic proximity Read ↗

Role of 5HT 2A and 5HT 2C polymorphisms in behavioural and psychological symptoms of Alzheimer's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.